Loading insider details...
Beta
Latest Form 4 (Oct 2, 2026): Grant/Award of 3,662 CCCC shares, $11.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 3,662 | $11.5K |
| Jul 2, 2026 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 2,650 | $11.5K |
| Jun 26, 2026 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 62,000 | n/a |
| Jun 4, 2026 | C4 Therapeutics, Inc. (CCCC) | Exercise/Conversion | 1,070 | $2.3K |
| Apr 3, 2026 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 4,259 | $11.5K |
| Jan 5, 2026 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 5,958 | $11.5K |
| Oct 3, 2025 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 5,349 | $11.5K |
| Jul 2, 2025 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 7,616 | $11.5K |
| Jun 20, 2025 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 35,500 | n/a |
| Apr 3, 2025 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 7,841 | $11.3K |